Tag Archives: markets

Buying Battery-Operated Cars

Posted on by
1

My then-new gasoline-powered 2022 Ford Escape and my wife’s new 2023 Ford Maverick hybrid, each one level down from Ford’s top tier, each cost in the low- to mid-$30 thousands. Joanna Stern, The Wall Street Journal‘s Senior Personal Technology Columnist, evaluated a number of battery-operated cars under $60,000 to see which one of those she liked best. The ones she looked into were the Ford Mustang Mach-E, Tesla Model Y, Hyundai Ioniq 5, Kia EV6, and Volkswagen ID.4.

The prices of these, as tested, were—oh, wait; she didn’t discuss equipage in any detail, nor did she name the price of those cars as tested. Accordingly, here are the prices I found after an arduous five minute Bing search. All prices, save Tesla, are via Edmunds; Tesla’s prices are per Tesla.

  • Mach-E: $42,500-$60,000, depending on how gussied up you want it
  • Model Y: $52,900-$66,000, depending….
  • Ioniq 5: $47,700-$59,400, depending….
  • EV6: $45,900-$60,200, depending….
  • 4: $40,300-$56,500, depending….

Assume, arguendo, that Stern’s evaluations are reasonable (noting that some of her criteria are matters of taste), and truncate the gussying to Stern’s $60,000 cap. This is the cost of transportation that the Progressive-Democrat Biden administration is trying to force us to pay in the name if its—and the Left’s—climate funding industry and related artificial hysteria.

This is just to get into the car, too; the comparison elides questions of range; the availability of charging stations outside the home garage; the long time to charge to the battery-operated cars’ 300-ish miles range (my Escape reaches 400+ miles on a tank of gas, and the tank fills in three minutes, or so); and of special importance to the Left (except when inconvenient to them); the environmental damage done by mining the raw materials and disposing of the spent batteries.

Drug Price…Foolishness

Posted on by
Reply

President Joe Biden (D) and his associates over in Medicare have identified the drugs of which he’s willing to pretend to negotiate the price. The particular drugs aren’t important; what matters is the precedent being set regarding the Progressive-Democrat-run administration’s view of what constitutes negotiation in Party’s lexicon. Readers interested in which drugs are targeted for now can find the list at the end of the linked-to article.

What’s important here is this.

The naming of the 10 drugs subject to price negotiations kicks off a lengthy process. Drugmakers have until October 1 to say whether they will join in the negotiations.
If they don’t negotiate or accept the price resulting from it, companies face a tax of up to 95% on a medicine’s US sales, or they can pull all of their drugs from Medicare and Medicaid coverage.

And this:

Drug makers that don’t participate or reject the government’s price will incur a crippling daily excise tax that starts at 186% and eventually climbs to 1,900% of the drug’s daily revenues. This is extortion, not a negotiation.

That’s not negotiation, that’s “Take our price, or pay even more through our usurious, if not confiscatory, taxes.” The outcome will be a stifling of medical (not just for medicinal) innovation in the US. Instead, innovation, such as might remain, will be pushed overseas, in large part to nations that don’t themselves innovate very much, having come to rely on American developments which they then heavily subsidize for their own citizens.

Some of those drugs, too, will be pulled from Medicare/Medicaid coverage, along with all of the other drugs a company makes available through those programs, which will price them out of reach of those most in need—those with the ailments being treated by those medicines and who lack the money to pay the full price.

That is, until Party takes the next obvious step and taxes those medicines’ sales revenues earned outside of Medicare/Medicaid, to be followed by Party’s diktat that those medicines must be offered through Medicare/Medicaid.

Which will result in those medicines no longer being manufactured in the US at all and no longer being sold at all in the US, regardless of their manufacture.

Increasing Choice

Posted on by
Reply

New Jersey’s Progressive-Democratic Party Governor Phil Murphy’s Newspeak definition of increasing choice as he applies it to vehicles he will permit his subjects the citizens of New Jersey to buy goes like this:

“There’s a lot of misinformation about what this order does,” his climate director Catherine Klinger said in an interview with ROI-NJ that was published this week. “It requires that new vehicle sales in the state are zero emission by 2035. More than 50% of vehicles that are sold in the state are used. And there is absolutely no change to the used vehicle market.”
If you like your Jeep Cherokee, you’ll still be able to buy a used one….

While supplies last.

No, Murphy’s proclamation, made through his climate director, is nothing more than a cynical variation on Henry Ford’s marketing slogan of a century ago:

The customer can have any color they want as long as it’s black. A New Jersey citizen can have any vehicle he wants, as long as it’s electric. Never mind whether he can afford one.

SEIA’s Response to Bidenomic’s Tariffs

Posted on by
Reply

The Wall Street Journal‘s editors correctly noted the internal—and intrinsic—contradictions in the Biden administration’s “renewable” energy demands and its trade policy. The administration is pushing ever harder to shift our economy, for good or ill (mostly ill IMNHO), to energy sourced to non-carbon-based, but renewable only—nuclear need not apply—producers. Then comes Gina Raimondo, Commerce Secretary, and her decision, backed by that same Joe Biden, to apply tariffs as high as 254% to solar power-related products imported from five People’s Republic of China enterprises, never minding that these companies are American domestic solar power producers’ primary sources of the needed articles.

But the Solar Energy Industries Association’s whine about the administration’s tariff policy leaped out at me.

It will take at least three to five years to ramp up domestic solar manufacturing capacity and the global supply chain will be vital in the short-term.

But would SEIA’s members actually ramp up domestic production without the tariffs, or would they simply continue buying from an enemy nation? SEIA is being disingenuous.

I’m not convinced that Commerce’s tariffs are the way to go—in general, they’re being applied as protectionist barriers rather than as foreign policy tools, and Commerce’s tariffs here are no exception—but SEIA’s plaints seem nothing more than excuse-making. After all, those members already have had those three to five years, and more, during which to ramp up domestic solar manufacturing capacity, and they’ve chosen not to do so.

Chip Manufacturing

Posted on by
Reply

The Biden administration is bent on bringing computer chip manufacturing back into the United States. On its face, that would seem beneficial. However, the administration team he’s formed to oversee the matter and its $39 billion of taxpayer dollars allocated to the program is populated with

investment bankers, private-equity investors, and management consultants.

And apparently no chip engineers or anyone familiar with supplying chip factories.

Uh, huh.

The Manhattan Project and the crash program to develop treatments for the Wuhan Virus were populated, strongly preferentially, with experts in the field, and they just as strongly deemphasized the moneybags experts.

That’s not the case with Biden’s nightmare dream team of money allocators. This isn’t a true crash program, certainly, but it’s still an effort to rapidly guts something up. It needs experts in the field to do the gutsing, it does not need politically connected money handlers.